Optimized Anti-FAP CAR-T Cells Demonstrate Enhanced Antitumor Persistence and Preclinical Safety
Researchers identified an optimized human VH domain-based CAR-T cell therapy targeting fibroblast activation protein that exhibited enhanced antitumor efficacy, persistence, ...










